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Background and Significance

Kalman, Morissette and George (2005), Am. J. Addict., 14: 106-123

• “Nicotine-dependent
individuals with a
comorbid psychiatric
disorder made up 7.1% of
the population yet
consumed 34.2% of all
cigarettes smoked in the
United States”

Grant, B.F. , Hasin, D.S., Chou, S.P., Stinson, F.S.& Dawson, D.A. (2004). Nicotine dependence and psychiatric
disorders in the United States: Results from a national epidemiologic survey on alcohol and related conditions. Archives
of General Psychiatry,61,1107-1115.

Individuals with SUD and PD are disproportionately
affected by tobacco caused mortality...
•In an 11 year retrospective study of 845 individuals who had received
residential treatment, more than half of all deaths were due to tobaccorelated causes.
•In a 24 year prospective study of heroin users in treatment, death rate of
smokers x4 (v non-smokers).
•Tobacco and alcohol can act synergistically….heavy users increase cancer
risk x 37 (v abstainers).
•Individuals with Schizophrenia have elevated rates of respiratory and
breast cancers and respiratory cancer deaths than individuals without
schizophrenia
Hurt RD et al (2006) Mortality following in-patient addictions treatment. JAMA.
Hser YI et al (1994) Tobacco use as a distal predictor of mortality among long-term narcotic addicts. Preventative Medicine.
Blot WJ (1992) Alcohol and Cancer. Cancer Research.
Osborn et al. (2007). Relative Risk of Cardiovascular and Cancer Mortality in People With Severe Mental Illness From the
United Kingdom's General Practice Research Database. Arch Gen Psychiatry

Reasons for Smoking among individuals with
co-morbid SUD and PD

• Genetic

• Biologic

• Psychosocial

Substance use and smoking

•

Both common and specific addictive factors for alcohol, marijuana,
cocaine, and habitual smoking transmitted in families

•

This specificity suggested independent causative factors for the
development of each substance dependence.
Bierut LJ, Dinwiddie SH, Begleiter H, et al. Familial Transmission of Substance Dependence: Alcohol, Marijuana, Cocaine, and Habitual
Smoking: A Report From the Collaborative Study on the Genetics of Alcoholism. Archives of General Psychiatry 1998; 55:982-988

Substance use and smoking

•

68% of the association between nicotine and alcohol
dependence explained by shared genetic effects.

True WR, Xian H, Scherrer JF, et al. Common Genetic Vulnerability for Nicotine and Alcohol Dependence in Men. Archives of General
Psychiatry 1999; 56:655-661

Mental health and smoking
(1,566 female twin pairs) average life
time daily cigarette consumption was
found to be associated with life time
prevalence of major depression,
suggesting that the relationship
between smoking and major
depression resulted solely from genes
which predispose to both conditions.
(8,169 male twins) shared
genetic disorders further
predispose to major
depression and nicotine
dependence.
Kendler KS, Neale MC, MacLean CJ, et al. Smoking and Major Depression: A Causal Analysis. Archives of General Psychiatry 1993;
50:36-43
Lyons M, Hitsman B, Xian H, et al. A twin study of smoking, nicotine dependence, and major depression in men. Nicotine & Tobacco
Research 2008; 10:97 - 108

Mental health and smoking

•

63% of the association between post traumatic stress disorder
and nicotine dependence co-morbidity was explained by
shared genetic effects.

Koenen KC, Hitsman B, Lyons MJ, et al. A Twin Registry Study of the Relationship Between Posttraumatic Stress Disorder and Nicotine
Dependence in Men. Archives of General Psychiatry 2005; 62:1258-1265

Mental health and smoking

•

Found a group of candidate genes and individual genes
among individuals with schizophrenia which were significantly
linked to smoking behaviors.

Faraone et al. (2004). A novel permutation testing method implicates sixteen nicotinic acetylcholine receptor genes as risk factors for
smoking in Schizophrenia families

Substance use and Smoking
Ford,Vu, Anthony Drug and
Alcohol Dependence 2002;
67:243-248

Marijuana use reduces cessation of tobacco
smoking in adults

Barrett,Tichauer, Leyton, et
al. Drug and Alcohol
Dependence 2006; 81:197-204

Nicotine increases alcohol self-administration
in non-dependent male smokers.

Story & Stark. Journal of
psychoactive drugs 1991;
23:203-215

increases in methadone dose could increase
nicotine craving and cigarette consumption for
opioid-dependent

Levine et al. Science
translational medicine 2011;
3, 107, 107-109

Cigarette smoking can prime the brain to cocaine use

Mental health and smoking
Postma et al.
Psychopharmacology (2006)
184: 589–599

nicotine reduces sensorimotor gating deficits in
smokers with schizophrenia

Barr, Culhane, Jubelt, et al.
Neuropsychopharmacology
2007; 33:480-490

administration of transdermal patch nicotine
improves attention and response inhibition in
nonsmokers with schizophrenia

Fowler, Volkow, Wang, et al.
Proceedings of the National
Academy of Sciences of the
United States of America
1996; 93:14065-14069

brain levels of monoamine oxidase A (MAO-A) (an
enzyme associated with depression) were reduced
in smokers relative to nonsmokers; suggesting that
people with affective disorders may smoke to
reduce elevated MAO-A levels in the brain

McCabe, Chudzik, Antony,
et al. Journal of Anxiety
Disorders 2004; 18:7-18

Smokers with a primary diagnosis of anxiety
disorder reported greater levels of general anxiety,
distress, and depression as compared to
nonsmokers.

Substance use and Smoking
• The use of other substances may foster tobacco use
• Drug treatment facilities may provide an environment
that supports tobacco use or a factor for delayed
tobacco use cessation.
• Factors such as neighborhood disadvantage and early
exposure to substance use may present an ‘exposure
opportunity’ for subsequent substance use.

Glautier S, Clements K, White JAW, et al. Alcohol and the reward value of cigarette smoking. Behavioural Pharmacology 1996; 7:144-154
King AC, Epstein AM. Alcohol Dose-Dependent Increases in Smoking Urge in Light Smokers. Alcoholism: Clinical & Experimental Research
2005; 29:547-552
Friend KB, Pagano ME. Smoking initiation among nonsmokers during and following treatment for alcohol u se disorders. Journal of Substance
Abuse Treatment 2004; 26:219-224
Bobo JK, Husten C. Sociocultural Influences on Smoking and Drinking. Alcohol Research & Health 2000; 24:225-232
Crum RM, Lillie-Blanton M, Anthony JC. Neighborhood environment and opportunity to use cocaine and other drugs in late childhood and early
adolescence. Drug and Alcohol Dependence 1996; 43:155-161
Wagner FA, Anthony JC. Into the world of illegal drug use: Exposure opportunity and other mechanisms linking the use of alcohol, tobacco,
marijuana, and cocaine. Am. J. Epidemiol. 2002; 155:918-925

Mental health and smoking
• History of tobacco use as a token economy-cigarettes used as a ‘reward’ for appropriate
behavior (i.e., smoking privileges)
• Smoking among clients and staff to encourage
‘socialization’

Kawachi I, Berkman L. Social ties and mental health. Journal of Urban Health 2001; 78:458-467
Lawn S. Cigarette smoking in psychiatric settings: occupational health, safety, welfare and legal concerns. Australian and New Zealand
Journal of Psychiatry 2005; 39:886-891
Keizer I, Eytan A. Variations in Smoking during Hospitalization in Psychiatric In-Patient Units and Smoking Prevalence in Patients and
Health-Care Staff. International Journal of Social Psychiatry 2005; 51:317-328
Morisano D, Bacher I, Audrain-McGovern J, et al. Mechanisms underlying the comorbidity of tobacco use in mental health and addictive
disorders. Canadian Journal Of Psychiatry. Revue Canadienne De Psychiatrie 2009; 54:356-367

Arguments for Not Providing Tobacco Treatment….

“these patients don’t want to quit”
• 80% of participants in a methadone maintenance program
and 75% of participants in an alcohol abuse program
endorsed a desire to quit
(Richter KP et al., 2001; Ellingstad TP et al, 1999)

• In a review of 9 studies of motivation to quit smoking among
individuals with psychiatric disorders at least 50% are
contemplating cessation
(Siru, Hulse & Tait, 2009).

“these patients will relapse (to other substances) if
they try to quit”
• Smoking cessation related to improved quality of life
• Meta-analysis (n = 19 studies) of smoking cessation among
individuals in addiction treatment and recovery found that
smoking cessation efforts can ENHANCE rather than
compromise long-term sobriety

Bobo JK, McIlvain HE, Lando HA, et al. Effect of smoking cessation counseling on recovery from alcoholism: findings from a randomized community
intervention trial. Addiction 1998; 93:877-887
McCarthy WJ, Zhou Y, Hser YI, et al. To smoke or not to smoke: Impact on disability, quality of life, and illicit drug use in baseline polydrug users. Journal
of Addictive Diseases 2002; 21:35-54
Lemon SC, Friedmann PD, Stein MD. The impact of smoking cessation on drug abuse treatment outcome. Addictive Behaviors 2003; 28:1323-1331
Mc Carthy WJ, Collins C, Hser YI. Does cigarette smoking affect drug abuse treatment? Journal of Drug Issues 2002; 2:61-80
Prochaska JJ, Delucchi K, Hall SM. A meta-analysis of smoking cessation interventions with individuals in substance abuse treatment or recovery.
Journal of Consulting and Clinical Psychology 2004; 72:1144-1156

“these patients are unable to quit”
• Meta-analysis (n = 19 studies) of smoking cessation among
individuals in addiction treatment and recovery found increased
cessation at end of 12 weeks treatment (BUT NO SIGNIFICANT
EFFECT AT 6 MONTHS!)
(Prochaska JJ et al, 2004).

• Recent study found end-of-treatment smoking cessation rates of
20% among individuals with psychiatric disorders accessing
outpatient tobacco treatment program
(Selby et al, 2010)

• Another recent study found end-of-treatment (between 8 to 26
weeks) smoking cessation rates of 40% among individuals with
SUD and/or PD who completed an intensive tailored smoking
cessation intervention that provided no-cost pharmacotherapy
combined with behavioural counseling
(Khara and Okoli, 2011)

Treating tobacco use in co-morbid
substance use and psychiatric populations

Longer treatment duration
100

Smoking Cessation by length of stay in the program (n = 678)*
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* Statistically significant differences between groups

Barriers to Facilitating tobacco treatment
Smoking cessation and concurrent substance use
treatment and recovery
• Treatment of smoking cessation does not exacerbate the use or
lead to relapse of another substanceo meta-analysis found summary relative risk was 1.25 (95% CI, 1.07–1.46)

indicating a significant increase in the likelihood of abstinence from
substance use among those in smoking cessation treatment as compared
with the control condition

• Issues related to concurrent vs. sequential tobacco treatment for
individuals with alcohol useo study found no difference in the cessation rates at 18 months (12.4% vs.
13.7%) but prolonged alcohol abstinence for 30 days and 6 months was
worse in the concurrent group than in the delayed group at 6, 12 and 18
months.
Prochaska JJ, Delucchi K, Hall SM. A meta-analysis of smoking cessation interventions with individuals in substance abuse treatment or recovery. Journal of
Consulting and Clinical Psychology 2004; 72:1144-1156
Joseph AM, Willenbring ML, Nugent SM, et al. A randomized trial of concurrent versus delayed smoking intervention for patients in alcohol
dependence treatment *. Journal of Studies on Alcohol 2004; 65:681(611)

Role of smoking cessation in mental health services
• Concerns that smoking cessation will increase psychiatric symptoms
or relapse among patients.
o Among individuals with depression, smoking cessation related to increased
depression symptomatology, which is one of the symptoms of the nicotine
withdrawal syndrome
o individuals with anxiety disorders and depression report more severe
withdrawal symptoms
o smoking is associated with improvements in prepulse inhibition and sensory
gating which may be affected by smoking cessation

• Smoke-free policy and mental health facilities
o a review of studies examining prohibitions of smoking in psychiatric facilities
suggests that prohibitions do not have long-term effects on behavioral unrest or
noncompliance, but neither do they appear to effect smoking cessation

Patten C, Martin J. Does nicotine withdrawal affect smoking cessation? Clinical and theoretical issues. Annals of Behavioral Medicine 1996; 18:190-200
Breslau N, Kilbey MM, Andreski P. Nicotine withdrawal symptoms and psychiatric disorders: findings from an epidemiologic study of young adults. American Journal of Psychiatry 1992;
149:464-469
Adams CE, Stevens KE. Evidence for a role of nicotinic acetylcholine receptors in schizophrenia. Frontiers in Bioscience 2007; 12:4755-4772
Kumari V, Postma P. Nicotine use in schizophrenia: The self medication hypotheses. Neuroscience & Biobehavioral Reviews 2005; 29:1021-1034
el-Guebaly N, Cathcart J, Currie S, et al. Public health and therapeutic aspects of smoking bans in mental health and addiction settings. Psychiatr Serv 2002; 53:1617-1622
Ziedonis DMa, Williams JMb. Management of smoking in people with psychiatric disorders. Current Opinion in Psychiatry 2003; 16:305-315

Costs associated with smoking cessation treatment
• Even though less expensive than purchasing cigarettes, the cost of
pharmacotherapy and counseling presents an important barrier to
seeking treatment
• Such cost barriers to accessing treatment and the potential costeffectiveness of treatment have prompted guidelines about
reducing medication costs (reduced cost or free of charge),
inclusion of medications as benefits on drug insurance plans, and
setting up systems for reimbursement for tobacco cessation
treatment for health care providers.
Bansal MA, Cummings KM, Hyland A, et al. Stop-smoking medications: Who uses them, who misuses them, and who is misinformed about them?
Nicotine & Tobacco Research 2004; 6:303-310
Reilly P, Murphy L, Alderton D. Challenging the smoking culture within a mental health service supportively. International Journal of Mental Health
Nursing 2006; 15:272-278
Fiore M, Jaén C, Baker T, et al. A Clinical Practice Guideline for Treating Tobacco Use and Dependence: 2008 Update: A U.S. Public Health Service
Report. American Journal of Preventive Medicine 2008; 35:158-176
Raw M, McNeill A, West R. Smoking cessation: evidence based recommendations for the healthcare system. British Medical Journal 1999; 318:182-185

Tobacco Use and Cessation
in Homeless Populations
Case Example:
Salvation Army Clinic Tobacco Treatment Program

Kentucky Continues to be National
Leader in Adult Cigarette Smoking
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Homelessness & Tobacco
Use
• Specific data is limited but indicate higher levels of
cardiovascular and lung disease in homeless or
recently homeless persons
• Infectious disease concerns from sharing
cigarettes/smoking butts on the street
• Multiple stressors and lack of access to treatment
contribute to high prevalence of smoking

Factors contributing to high smoking
rates in the homeless include:
 substance abuse
 lack of shelter and the stress of caring for family and
children while homeless, lack of private living conditions
 lack of social support and lack of care from
society/social empathy
 low self esteem
 unemployment
 lack of education
 hunger and starvation (smoking has been linked to food
insecurity due to the appetite suppressing effects of
nicotine)
 little or no access to healthcare
 tobacco use among peers

Benefits of Quitting for the Homeless:
• Lower financial strain of smoking
• Less tobacco related illness for smoker and their
family (less SHS exposure)
• Treatment for other substance use is more likely to
be successful
• Increased self-efficacy
• Social normalization

Recommendations of Expert Panel on
Reducing Tobacco Effects in the
Homeless:
• Having all facility staff committed to tobacco
cessation and decreasing tobacco use among
their clients
• Providing access to NRT and a safe and smoke-free
environment will increase the chances that a client
can quit tobacco successfully
• Treatment for nicotine addiction should be
integrated into a comprehensive approach to
improving the overall health of clients.

Helping Tobacco Users Quit at the SAC
• Smoking Cessation Group started in Spring of 2010 with
a Chest Foundation Grant (Dr. Don Hayes) of $5000
• Students worked with UK Tobacco Treatment Specialist
to develop format for the group
• An open group format, provision of medication
(primarily NRT, PAP applications for Chantix), quit kits,
and contingency reward program ($5 gift cards for
abstinence) was developed

What’s Working
• Nicotine replacement has been a critical element
of the program
• Structured accountability to the group
• Reward cards
• “Café” atmosphere
• Motivational counseling/goal setting
• Great student involvement
• Smooth transition of leadership at end of student
experience

Challenges
•
•
•
•
•
•

Limited funding
Limited funding
Limited funding…
Transiency of the participants
Dedicated meeting space
Smoking area

How We Do What We Do
Motivational Counseling:
Meet the client “where they are”
Draw on strengths
Work positively to overcome barriers
Promote individualized goal setting over specific
time frame
Celebrate successes

Nicotine Replacement
• Dose/form tailored to the individual
• Use patch (21 mg/14 mg/7 mg) and/or gum and/or
lozenges (2 or 4 mg.)
• Given out for 1 week duration
• Use encouraged if smoking > ½ pack/day
• Dose based on current smoking (each cigarette is
approx. 2-3 mg. nicotine)

Oral Medications
• Chantix not routinely prescribed due to expense
(approx. $135/month) but is available through PAP if
sent to clinic
• Bupropion SR is contraindicated with a history of
seizures, not available through PAP but is on some
of Medicaid formularies; can be used with NRT
• Need to ensure follow up to monitor for side effects

Student Involvement
• Opportunity to work on tobacco cessation, the
leading cause of morbidity and mortality, in a
challenging setting
• Develop motivational interviewing skills
• Fun group to work with!
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